Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Medication Research of Warfarin Based on Vascular Aging Assessment

NCT06428110 is registered in ClinicalTrials.gov with Haobin Li as lead sponsor.

NCT NCT06428110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06428110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Medication Research of Warfarin Based on Vascular Aging Assessment
Lead sponsor
Haobin Li
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
December 12, 2023
Enrollment
272 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

warfarin sodium causing adverse effects in therapeutic use